[web_stories title="false" excerpt="false" author="false" date="false" archive_link="true" archive_link_label="" circle_size="150" sharp_corners="false" image_alignment="left" number_of_columns="1" number_of_stories="5" order="DESC" orderby="post_title" view="circles" /]
Antibody-resistant Omicron BQ Variations Are Increasingly Prevalent in the US
According to the Centers for Disease Control and Prevention, Omicron subvariants will soon account for the bulk of new Covid infections in the U.S. According to CDC data, Omicron subvariants BQ.1 and BQ.1.1 currently account for 44% of new Covid cases compared to 32% last week. In the coming week, these subvariants will probably start to dominate.
Meanwhile, the once-dominant omicron BA.5 is being dislodged and now accounts for 29% of new infections. People with highly weakened immune systems, such as organ transplant recipients and cancer patients receiving chemotherapy, are particularly at risk from BQ.1 and BQ.1.1. People with weakened immune systems frequently may not respond adequately to the Covid vaccinations and so require extra drugs to provide them with viral protection.
Health & Science on CNBC
Check out CNBC’s most recent articles on global health: According to the CDC, unvaccinated newborns were hospitalized with Covid more frequently this summer than most age groups. Kentucky rejects a constitutional proposal that forbids abortion, winning an unexpected victory for reproductive rights.
Despite a deficit in the third quarter, Novavax exceeded revenue projections. Young children and the elderly are most at risk as the U.S. experiences its highest hospitalization rate for the flu in a decade. In these states, the question of abortion rights is on the ballot. What you should know for the midterms is provided below.
Pfizer makes available additional evidence that omicron boosters are superior to the older Covid injections.
The number of Covid deaths in the United States is still too high, and new omicron variations are developing, according to Fauci.
What to do in the event that a Covid test results in a positive result just before a Thanksgiving or holiday gathering. After the Covid vaccine producer cuts the 2022 revenue outlook, Moderna shares decline. Covid talks are now more difficult than ever; these 3 professional methods can help.
Pfizer’s CEO unveils his company’s 2030 growth strategy as generic competition could cost it $18 billion in revenue. Pfizer beats third-quarter projections and increases its earnings forecast for 2022. According to a federal assessment, women are more affected by Long Covid than men.
Every week, the number of Omicron subvariants resistant to important antibody therapies rises in the United States. Omicron boosters weren’t significantly better than previous Covid shots, according to two studies, but the FDA believes they were too tiny to draw any firm conclusions.
Evusheld, an antibody cocktail, is frequently taken by persons with moderately or severely weakened immune systems in order to protect them against life-threatening illnesses. Every six months, it is given as two shots. The National Institutes of Health state that Evusheld is probably not effective against BQ.1 and BQ.1.1. As these subvariants proliferate, persons with weakened immune systems become more and more vulnerable.
Bebtelovimab, a monoclonal antibody that persons with weakened immune systems can use to prevent serious illness from Covid following an infection, is likely resistant to BQ.1 and BQ.1.1 as well. Paxlovid, an antiviral from Pfizer, is still effective but is frequently ineffective for organ transplant patients due to interactions with other medications they require.
In a radio interview last week, White House Chief Medical Advisor Dr. Anthony Fauci stated that as the more immunological evading BQ subvariants rise on a weekly basis, the United States is reaching a turning point in the pandemic.
If these more recent versions end up dominating the market any more than they currently do, Fauci warned, “some of our tools in our arsenal may be negated.” Additionally, no alternatives to medications like Evusheld are under development. Dr. Ashish Jha, the director of the White House’s COVID response, has accused Congress of neglecting to approve additional financing for the country’s pandemic response. Since the spring, Republicans have stopped more Covid funding.
Jha told reporters at the White House this month, “We had thought that over time as the pandemic went along, as our fight against this virus went along, we would be growing our medicine cabinet. According to Jha, “vulnerable people are at risk since the medicine cupboard has actually reduced due to a lack of congressional financing.”
Joe Biden, the president, stated last month that this winter, Covid poses a unique hazard to persons with weakened immune systems. The president advised them to discuss safety measures with their doctors. Fauci advised wearing masks indoors in public this fall and winter for those who have vulnerable people in their homes as well as those who have a high risk of contracting Covid.
Before attending indoor social gatherings where vulnerable people will be present, people should think about getting quick Covid testing, according to Fauci. He urged everyone who could to get a flu vaccination and a Covid booster this fall.
Utilizing tests, donning masks when necessary, and receiving vaccinations are all excellent ways to ensure that you don’t transfer infections, he said. Because BQ.1 and BQ.1.1 are related to BA.5, U.S. health officials believe the omicron BA.5 boosters should offer adequate defense for the general populace against these subvariants.